Search Results
Jul 28, 2026, 10:44 ET Are NG, BLFS, NRIM Obtaining Fair Deals for their Shareholders?
NOVAGOLD RESOURCES INC. (NYSE American: NG)'s merger with Donlin Gold LLC. If you are a NOVAGOLD shareholder,
More news about: Halper Sadeh LLP
Jul 23, 2026, 10:31 ET ALK Inhibitors Market Set for Transformational Growth at a CAGR of 4% During the Forecast Period (2026-2036) Backed by Next-Generation Targeted Therapies| DelveInsight
studies primarily focused on combination treatment strategies.The growing implementation of molecular diagnostics, next-generation sequencing (NGS), and precision medicine is enhancing the detection of ALK-positive patients, enabling wider adoption of ALK-targeted therapies across eligible populations.Crizotinib,
More news about: DelveInsight Business Research, LLP
Jul 22, 2026, 09:00 ET Cepheid to Unveil Third-Generation GeneXpert® System at ADLM 2026, Advancing Molecular Diagnostic Capabilities
applications, including high-plex panel testing, fast time-to-result, and sample-to-answer solutions that may extend to next-generation sequencing (NGS) workflows."Healthcare providers increasingly need access to different types of molecular testing, yet those capabilities are often spread across
More news about: Cepheid
Jul 22, 2026, 09:00 ET Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges
network.Redefining genomic discovery with next-generation sequencing by expansion (SBX)The AXELIOS 1 next-generation sequencing (NGS) platform*, powered by sequencing by expansion (SBX) technology, is designed to make genomics research faster, more flexible and more affordable for
More news about: Roche
Jul 21, 2026, 08:30 ET Company Selected for Ability to Help Accelerate Planning and Deployment of AI Initiatives
HERNDON, Va., July 21, 2026 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS –
More news about: EPLUS INC.
Jul 20, 2026, 07:37 ET YY Group Appoints Former Changi Airport Executive Ng Yansheng as Managing Director of YY Circle (SG) Pte. Ltd. to Drive Next Phase of Growth
and leveraging technology to optimize operational efficiency."As the gig economy and flexible workforce models rapidly evolve, we believe Mr. Ng's deep expertise in business operations and transformation makes him the ideal leader for our Singapore operations," said Mike Fu, Chairman and Chief
More news about: YY Group Holding Limited
Jul 17, 2026, 10:15 ET Bioinformatics Market worth $34.41 billion by 2031 - Exclusive Report by MarketsandMarkets™
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39The bioinformatics market is driven by the increased adoption of next-generation sequencing (NGS) technology, greater funding for genomics and precision medicine, and high demand for faster, large-scale biological data analysis. Moreover, the growing
More news about: MarketsandMarkets
Jul 16, 2026, 10:30 ET Oligonucleotide Synthesis Market worth $32.72 billion by 2031 - Exclusive Report by MarketsandMarkets™
Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), and Application (Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)) - Global Forecast to 2030
More news about: MarketsandMarkets
Jul 14, 2026, 10:31 ET Alport Syndrome Market to Grow at a Tremendous 47% CAGR Through 2036, Driven by Emerging Therapies and Expanding Clinical Pipeline | DelveInsight
Diagnosis: Growing awareness among healthcare professionals and patients, coupled with advances in genetic testing and next-generation sequencing (NGS), has significantly improved the early diagnosis of Alport syndrome.Increasing Adoption of Precision Medicine: The shift toward precision
More news about: DelveInsight Business Research, LLP
Jul 14, 2026, 10:00 ET Geneseeq Canada Named First Genomic Testing Partner in UHN's SHERLOCK Study
subsidiary of Geneseeq, a global precision oncology company advancing cancer detection, diagnosis, and treatment through next-generation sequencing (NGS) technologies. Headquartered in Ontario, Canada, the company operates CAP- and CLIA-certified laboratory that supports cancer genomic research, precision
More news about: Geneseeq Technology Inc.
Jul 14, 2026, 08:30 ET Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing
Personalized Care: Integration of PTEN IHC with Caris' broader multi-platform molecular profiling approach including next-generation sequencing (NGS) provides a more complete understanding of tumor biology to guide therapy selection.The introduction of PTEN IHC testing reflects a broader evolution
More news about: Caris Life Sciences
Jul 09, 2026, 10:46 ET Global Pharmacogenomic Testing Service Market to Register Stunning Growth at a CAGR of ~12% by 2034 | DelveInsight
for these patient populations.Advancements in Genomic Sequencing Technologies: Continuous innovations in next-generation sequencing (NGS), PCR-based assays, and bioinformatics have improved the speed, accuracy, and affordability of pharmacogenomic testing. These technological developments
More news about: DelveInsight Business Research, LLP
Jul 06, 2026, 08:30 ET ePlus Appoints John Lutz to Board of Directors
HERNDON, Va., July 6, 2026 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS –
More news about: EPLUS INC.
Jul 03, 2026, 10:30 ET Biomarkers Market worth $112.10 billion by 2031 | MarketsandMarkets™
https://www.marketsandmarkets.com/requestsampleNew.asp?id=43In 2025, the NGS segment is expected to be the fastest-growing in the global biomarkers market, by technology.The global biomarkers market is divided by technology into several categories: immunoassays, next-generation sequencing (NGS), polymerase chain reaction (PCR),
More news about: MarketsandMarkets
Jul 03, 2026, 07:00 ET AerCap Leased, Purchased and Sold 202 Assets in the Second Quarter 2026
helicopters. Completed 49 sale transactions for 45 aircraft (including 15 Airbus A320 Family aircraft, 14 Airbus A320neo Family aircraft, 1 Airbus A350, 2 Boeing 737NGs, 1 Boeing 787-8, 1 Boeing 767-300ERF and 1 Embraer E195-E2 from AerCap's owned portfolio and 10 aircraft from AerCap's managed portfolio), 2 engines
More news about: AerCap Holdings N.V.
Jul 03, 2026, 04:03 ET Startup Island TAIWAN-Led Delegation Secures More Than 100 Business Meetings at BIO 2026, Expanding Global Opportunities for Taiwanese Biotech Startups
AB DigiHealth Inc.AB DigiHealth develops AI-powered reproductive healthcare solutions that combine genomics, next-generation sequencing (NGS), and clinical expertise. Its flagship product, icONE, integrates embryo genomic data and maternal health parameters to predict embryo implantation
More news about: DCB
Jul 02, 2026, 10:46 ET Global DNA Diagnostics Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2034 | DelveInsight
response, and therapeutic targets.Technological Advancements in Polymerase Chain Reaction: Innovations such as next-generation sequencing (NGS), polymerase chain reaction (PCR), microarrays, and CRISPR-based diagnostics have significantly improved the speed, accuracy, and affordability of DNA
More news about: DelveInsight Business Research, LLP
Jul 02, 2026, 10:30 ET Label Identification Technologies Market worth $2.87 billion by 2031 | MarketsandMarkets™
shaping the label identification market is the growing adoption of advanced molecular and genomic technologies, including next-generation sequencing (NGS), multiplex PCR, digital PCR, and syndromic testing platforms, for rapid, accurate identification of pathogens, microorganisms, and genetic markers.
More news about: MarketsandMarkets
Jul 02, 2026, 06:30 ET Partner Therapeutics Announces Publication of Results From the eNRGy Trial of Zenocutuzumab in Patients with NRG1+ Cholangiocarcinoma in Journal of Clinical Oncology (JCO)
efficacy. Most patients were pre-treated, with a median of one prior line of therapy (range up to 6). Notably, RNA-based next-generation sequencing (NGS) identified 100% of NRG1 fusions, compared with 29% detected by DNA-based testing.The investigator-assessed overall response rate (ORR),
More news about: Partner Therapeutics, Inc.
Jul 01, 2026, 11:21 ET MGI Tech Launches Go Spatial in Europe and Expands STOmics Partner Network at STOC 2026
in multi-omics technologies for life science research. Its service portfolio spans single-cell and spatial multi-omics, next-generation sequencing (NGS), and bioinformatics analysis.Omics Empower has contributed to more than 500 peer-reviewed research papers on single-cell and spatial omics, including
More news about: MGI Tech Co., Ltd.
Jul 01, 2026, 08:30 ET ePlus Surpasses Industry Benchmarks with Outstanding Net Promoter Score in Independent Survey
HERNDON, Va., July 1, 2026 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS) (news) today announced that in
More news about: EPLUS INC.
Jul 01, 2026, 08:00 ET MiDOG Animal Diagnostics Launches First Dedicated NGS-Based Parasite Detection Test for Veterinary Medicine
in next-generation sequencing-based veterinary diagnostics, today announced the launch of MiDOG Parasite-Only Testing, a first-of-its-kind dedicated NGS-based parasite detection test for veterinary medicine.
More news about: MiDOG Animal Diagnostics
Jun 30, 2026, 10:00 ET Zymo Research Joins BLOODPAC to Advance Standards for Liquid Biopsy
sample collection, DNA/RNA purification, library preparation, microbiomics, transcriptomics, epigenomics, genomics, and Next-Generation Sequencing (NGS) services.In addition to its cutting-edge technologies, Zymo Research is committed to
More news about: Zymo Research Corp.
Jun 30, 2026, 09:00 ET LogicGate Solidifies Position as the Enterprise AI GRC Leader With Its Spring 2026 Release
Edwin Ng's appointment to Chief Information Security Officer (CISO), where he will lead the company's global resilience strategy, fortify Risk Cloud's security
More news about: LogicGate
Jun 30, 2026, 08:30 ET ePlus Recognized as Services Partner of the Year at Everpure Annual Accelerate Partner Forum
HERNDON, Va., June 30, 2026 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS –
More news about: EPLUS INC.